Leading Global Pharmaceutical Company Expands Contract with Dendrite to Support its Canadian Field Force
biz.yahoo.com
Friday September 16, 9:06 am ET
BEDMINSTER, N.J.--(BUSINESS WIRE)--Sept. 16, 2005--Dendrite International, Inc. (NASDAQ: DRTE), a leading provider of sales, marketing and clinical solutions for the life science and pharmaceutical industries, today announced that the Canadian subsidiary of a leading global pharmaceutical company purchased additional licenses of Dendrite's WebForce(TM) and Analyzer(TM) solutions -- both core components of Dendrite's First Source(TM) Sales Applications solution suite that helps pharmaceutical and life science companies manage all aspects of their sales force activities. Dendrite is also providing support services to these additional users.
WebForce optimizes and coordinates promotional activities across sales teams, improves communications, and streamlines new product launches. Dendrite's Analyzer solution enables multiple field organizations to understand the impact of call activity and evaluate ongoing actions for the delivery of timely information to targeted physicians.
"We are pleased to have extended our partnership with this leading pharmaceutical company," said Natasha Giordano, senior vice president at Dendrite. "We look forward to strengthening our partnership with them by continuing to deliver valuable support." |
